nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.16	0.232	CbGbCtD
Moclobemide—CYP2C19—Progesterone—uterine cancer	0.127	0.185	CbGbCtD
Moclobemide—CYP1A2—Progesterone—uterine cancer	0.117	0.17	CbGbCtD
Moclobemide—CYP2C9—Progesterone—uterine cancer	0.106	0.154	CbGbCtD
Moclobemide—CYP2D6—Progesterone—uterine cancer	0.0967	0.14	CbGbCtD
Moclobemide—CYP1A2—Etoposide—uterine cancer	0.0525	0.0763	CbGbCtD
Moclobemide—CYP2D6—Doxorubicin—uterine cancer	0.0295	0.0429	CbGbCtD
Moclobemide—MAOB—myometrium—uterine cancer	0.0017	0.0634	CbGeAlD
Moclobemide—MAOA—myometrium—uterine cancer	0.00145	0.0541	CbGeAlD
Moclobemide—MAOB—uterine cervix—uterine cancer	0.00132	0.0494	CbGeAlD
Moclobemide—MAOB—decidua—uterine cancer	0.00126	0.047	CbGeAlD
Moclobemide—MAOB—renal system—uterine cancer	0.00124	0.0462	CbGeAlD
Moclobemide—MAOB—endometrium—uterine cancer	0.0012	0.0447	CbGeAlD
Moclobemide—Stomatitis—Dactinomycin—uterine cancer	0.00117	0.00411	CcSEcCtD
Moclobemide—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00411	CcSEcCtD
Moclobemide—Loss of consciousness—Progesterone—uterine cancer	0.00117	0.0041	CcSEcCtD
Moclobemide—MAOB—mammalian vulva—uterine cancer	0.00116	0.0432	CbGeAlD
Moclobemide—Hypertension—Progesterone—uterine cancer	0.00115	0.00403	CcSEcCtD
Moclobemide—Chest pain—Progesterone—uterine cancer	0.00113	0.00397	CcSEcCtD
Moclobemide—Myalgia—Progesterone—uterine cancer	0.00113	0.00397	CcSEcCtD
Moclobemide—MAOA—uterine cervix—uterine cancer	0.00113	0.0421	CbGeAlD
Moclobemide—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00396	CcSEcCtD
Moclobemide—Anxiety—Progesterone—uterine cancer	0.00113	0.00396	CcSEcCtD
Moclobemide—Discomfort—Progesterone—uterine cancer	0.00112	0.00393	CcSEcCtD
Moclobemide—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00392	CcSEcCtD
Moclobemide—Gingivitis—Epirubicin—uterine cancer	0.00111	0.0039	CcSEcCtD
Moclobemide—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00389	CcSEcCtD
Moclobemide—Dry mouth—Progesterone—uterine cancer	0.00111	0.00389	CcSEcCtD
Moclobemide—MAOB—uterus—uterine cancer	0.0011	0.0411	CbGeAlD
Moclobemide—Confusional state—Progesterone—uterine cancer	0.00109	0.00384	CcSEcCtD
Moclobemide—Dermatitis atopic—Doxorubicin—uterine cancer	0.00109	0.00383	CcSEcCtD
Moclobemide—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00381	CcSEcCtD
Moclobemide—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00379	CcSEcCtD
Moclobemide—MAOA—decidua—uterine cancer	0.00108	0.0401	CbGeAlD
Moclobemide—Shock—Progesterone—uterine cancer	0.00107	0.00375	CcSEcCtD
Moclobemide—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00374	CcSEcCtD
Moclobemide—Tachycardia—Progesterone—uterine cancer	0.00106	0.00372	CcSEcCtD
Moclobemide—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00372	CcSEcCtD
Moclobemide—MAOA—renal system—uterine cancer	0.00106	0.0394	CbGeAlD
Moclobemide—Hyperhidrosis—Progesterone—uterine cancer	0.00105	0.00368	CcSEcCtD
Moclobemide—Gingivitis—Doxorubicin—uterine cancer	0.00103	0.00361	CcSEcCtD
Moclobemide—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.0036	CcSEcCtD
Moclobemide—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.0036	CcSEcCtD
Moclobemide—MAOA—endometrium—uterine cancer	0.00102	0.0381	CbGeAlD
Moclobemide—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00359	CcSEcCtD
Moclobemide—Hypotension—Progesterone—uterine cancer	0.00101	0.00356	CcSEcCtD
Moclobemide—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00356	CcSEcCtD
Moclobemide—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.001	0.00352	CcSEcCtD
Moclobemide—Flushing—Dactinomycin—uterine cancer	0.001	0.00352	CcSEcCtD
Moclobemide—MAOB—female reproductive system—uterine cancer	0.000992	0.037	CbGeAlD
Moclobemide—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00099	0.00348	CcSEcCtD
Moclobemide—MAOA—mammalian vulva—uterine cancer	0.000988	0.0369	CbGeAlD
Moclobemide—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000987	0.00347	CcSEcCtD
Moclobemide—Insomnia—Progesterone—uterine cancer	0.00098	0.00344	CcSEcCtD
Moclobemide—Paraesthesia—Progesterone—uterine cancer	0.000973	0.00342	CcSEcCtD
Moclobemide—Dyspnoea—Progesterone—uterine cancer	0.000966	0.0034	CcSEcCtD
Moclobemide—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000966	0.0034	CcSEcCtD
Moclobemide—Somnolence—Progesterone—uterine cancer	0.000963	0.00339	CcSEcCtD
Moclobemide—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000958	0.00337	CcSEcCtD
Moclobemide—Dyspepsia—Progesterone—uterine cancer	0.000954	0.00335	CcSEcCtD
Moclobemide—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000949	0.00334	CcSEcCtD
Moclobemide—Decreased appetite—Progesterone—uterine cancer	0.000942	0.00331	CcSEcCtD
Moclobemide—MAOA—uterus—uterine cancer	0.000941	0.0351	CbGeAlD
Moclobemide—Fatigue—Progesterone—uterine cancer	0.000934	0.00328	CcSEcCtD
Moclobemide—Constipation—Progesterone—uterine cancer	0.000927	0.00326	CcSEcCtD
Moclobemide—Dysarthria—Epirubicin—uterine cancer	0.000921	0.00324	CcSEcCtD
Moclobemide—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000918	0.00322	CcSEcCtD
Moclobemide—MAOB—female gonad—uterine cancer	0.000902	0.0337	CbGeAlD
Moclobemide—MAOB—vagina—uterine cancer	0.000897	0.0335	CbGeAlD
Moclobemide—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000895	0.00314	CcSEcCtD
Moclobemide—Feeling abnormal—Progesterone—uterine cancer	0.000893	0.00314	CcSEcCtD
Moclobemide—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000888	0.00312	CcSEcCtD
Moclobemide—Gastrointestinal pain—Progesterone—uterine cancer	0.000886	0.00311	CcSEcCtD
Moclobemide—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000882	0.0031	CcSEcCtD
Moclobemide—CYP1A2—renal system—uterine cancer	0.000881	0.0329	CbGeAlD
Moclobemide—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000876	0.00308	CcSEcCtD
Moclobemide—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000873	0.00307	CcSEcCtD
Moclobemide—Ill-defined disorder—Dactinomycin—uterine cancer	0.000871	0.00306	CcSEcCtD
Moclobemide—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000864	0.00304	CcSEcCtD
Moclobemide—Urticaria—Progesterone—uterine cancer	0.000861	0.00303	CcSEcCtD
Moclobemide—Abdominal pain—Progesterone—uterine cancer	0.000857	0.00301	CcSEcCtD
Moclobemide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000854	0.003	CcSEcCtD
Moclobemide—Dysarthria—Doxorubicin—uterine cancer	0.000852	0.00299	CcSEcCtD
Moclobemide—Stomatitis—Etoposide—uterine cancer	0.000847	0.00298	CcSEcCtD
Moclobemide—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000847	0.00298	CcSEcCtD
Moclobemide—Malaise—Dactinomycin—uterine cancer	0.000846	0.00297	CcSEcCtD
Moclobemide—MAOA—female reproductive system—uterine cancer	0.000846	0.0316	CbGeAlD
Moclobemide—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00084	0.00295	CcSEcCtD
Moclobemide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000809	0.00284	CcSEcCtD
Moclobemide—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000803	0.00282	CcSEcCtD
Moclobemide—Myalgia—Dactinomycin—uterine cancer	0.000799	0.00281	CcSEcCtD
Moclobemide—Discomfort—Dactinomycin—uterine cancer	0.000789	0.00277	CcSEcCtD
Moclobemide—CYP2C19—vagina—uterine cancer	0.000782	0.0292	CbGeAlD
Moclobemide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00078	0.00274	CcSEcCtD
Moclobemide—Asthenia—Progesterone—uterine cancer	0.000778	0.00273	CcSEcCtD
Moclobemide—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000776	0.00273	CcSEcCtD
Moclobemide—MAOA—female gonad—uterine cancer	0.00077	0.0287	CbGeAlD
Moclobemide—Pruritus—Progesterone—uterine cancer	0.000767	0.00269	CcSEcCtD
Moclobemide—MAOA—vagina—uterine cancer	0.000765	0.0285	CbGeAlD
Moclobemide—Diarrhoea—Progesterone—uterine cancer	0.000741	0.00261	CcSEcCtD
Moclobemide—Flushing—Etoposide—uterine cancer	0.000724	0.00254	CcSEcCtD
Moclobemide—Dizziness—Progesterone—uterine cancer	0.000717	0.00252	CcSEcCtD
Moclobemide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000705	0.00248	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000698	0.00245	CcSEcCtD
Moclobemide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000695	0.00244	CcSEcCtD
Moclobemide—Vomiting—Progesterone—uterine cancer	0.000689	0.00242	CcSEcCtD
Moclobemide—Rash—Progesterone—uterine cancer	0.000683	0.0024	CcSEcCtD
Moclobemide—Dermatitis—Progesterone—uterine cancer	0.000683	0.0024	CcSEcCtD
Moclobemide—Headache—Progesterone—uterine cancer	0.000679	0.00239	CcSEcCtD
Moclobemide—Hot flush—Epirubicin—uterine cancer	0.000676	0.00238	CcSEcCtD
Moclobemide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000672	0.00236	CcSEcCtD
Moclobemide—Menopausal symptoms—Epirubicin—uterine cancer	0.00067	0.00235	CcSEcCtD
Moclobemide—CYP2C9—female reproductive system—uterine cancer	0.00067	0.025	CbGeAlD
Moclobemide—Decreased appetite—Dactinomycin—uterine cancer	0.000666	0.00234	CcSEcCtD
Moclobemide—Dysgeusia—Etoposide—uterine cancer	0.000665	0.00234	CcSEcCtD
Moclobemide—Fatigue—Dactinomycin—uterine cancer	0.00066	0.00232	CcSEcCtD
Moclobemide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000649	0.00228	CcSEcCtD
Moclobemide—Nausea—Progesterone—uterine cancer	0.000644	0.00226	CcSEcCtD
Moclobemide—Osteoarthritis—Epirubicin—uterine cancer	0.000632	0.00222	CcSEcCtD
Moclobemide—Feeling abnormal—Dactinomycin—uterine cancer	0.000631	0.00222	CcSEcCtD
Moclobemide—Ill-defined disorder—Etoposide—uterine cancer	0.00063	0.00221	CcSEcCtD
Moclobemide—CYP2D6—renal system—uterine cancer	0.000628	0.0234	CbGeAlD
Moclobemide—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000626	0.0022	CcSEcCtD
Moclobemide—Hot flush—Doxorubicin—uterine cancer	0.000625	0.0022	CcSEcCtD
Moclobemide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000624	0.00219	CcSEcCtD
Moclobemide—Migraine—Epirubicin—uterine cancer	0.000622	0.00219	CcSEcCtD
Moclobemide—Menopausal symptoms—Doxorubicin—uterine cancer	0.00062	0.00218	CcSEcCtD
Moclobemide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000619	0.00218	CcSEcCtD
Moclobemide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000619	0.00217	CcSEcCtD
Moclobemide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000615	0.00216	CcSEcCtD
Moclobemide—Malaise—Etoposide—uterine cancer	0.000613	0.00215	CcSEcCtD
Moclobemide—Abdominal pain—Dactinomycin—uterine cancer	0.000606	0.00213	CcSEcCtD
Moclobemide—Loss of consciousness—Etoposide—uterine cancer	0.000597	0.0021	CcSEcCtD
Moclobemide—Hypertension—Etoposide—uterine cancer	0.000586	0.00206	CcSEcCtD
Moclobemide—Osteoarthritis—Doxorubicin—uterine cancer	0.000585	0.00206	CcSEcCtD
Moclobemide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000583	0.00205	CcSEcCtD
Moclobemide—MAOB—lymph node—uterine cancer	0.00058	0.0216	CbGeAlD
Moclobemide—Dry skin—Epirubicin—uterine cancer	0.00058	0.00204	CcSEcCtD
Moclobemide—Chest pain—Etoposide—uterine cancer	0.000578	0.00203	CcSEcCtD
Moclobemide—Migraine—Doxorubicin—uterine cancer	0.000576	0.00202	CcSEcCtD
Moclobemide—Discomfort—Etoposide—uterine cancer	0.000571	0.00201	CcSEcCtD
Moclobemide—Gastritis—Epirubicin—uterine cancer	0.00056	0.00197	CcSEcCtD
Moclobemide—Confusional state—Etoposide—uterine cancer	0.000559	0.00196	CcSEcCtD
Moclobemide—Abdominal distension—Epirubicin—uterine cancer	0.00055	0.00193	CcSEcCtD
Moclobemide—Asthenia—Dactinomycin—uterine cancer	0.00055	0.00193	CcSEcCtD
Moclobemide—Tachycardia—Etoposide—uterine cancer	0.000541	0.0019	CcSEcCtD
Moclobemide—Dry skin—Doxorubicin—uterine cancer	0.000536	0.00188	CcSEcCtD
Moclobemide—Hyperhidrosis—Etoposide—uterine cancer	0.000536	0.00188	CcSEcCtD
Moclobemide—Angina pectoris—Epirubicin—uterine cancer	0.000532	0.00187	CcSEcCtD
Moclobemide—Diarrhoea—Dactinomycin—uterine cancer	0.000524	0.00184	CcSEcCtD
Moclobemide—Hypotension—Etoposide—uterine cancer	0.000518	0.00182	CcSEcCtD
Moclobemide—Gastritis—Doxorubicin—uterine cancer	0.000518	0.00182	CcSEcCtD
Moclobemide—Dysuria—Epirubicin—uterine cancer	0.000511	0.0018	CcSEcCtD
Moclobemide—Abdominal distension—Doxorubicin—uterine cancer	0.000509	0.00179	CcSEcCtD
Moclobemide—CYP2D6—female reproductive system—uterine cancer	0.000503	0.0188	CbGeAlD
Moclobemide—Paraesthesia—Etoposide—uterine cancer	0.000498	0.00175	CcSEcCtD
Moclobemide—MAOA—lymph node—uterine cancer	0.000495	0.0185	CbGeAlD
Moclobemide—Dyspnoea—Etoposide—uterine cancer	0.000494	0.00174	CcSEcCtD
Moclobemide—Somnolence—Etoposide—uterine cancer	0.000493	0.00173	CcSEcCtD
Moclobemide—Angina pectoris—Doxorubicin—uterine cancer	0.000493	0.00173	CcSEcCtD
Moclobemide—Drowsiness—Epirubicin—uterine cancer	0.000487	0.00171	CcSEcCtD
Moclobemide—Vomiting—Dactinomycin—uterine cancer	0.000487	0.00171	CcSEcCtD
Moclobemide—Rash—Dactinomycin—uterine cancer	0.000483	0.0017	CcSEcCtD
Moclobemide—Decreased appetite—Etoposide—uterine cancer	0.000482	0.00169	CcSEcCtD
Moclobemide—Fatigue—Etoposide—uterine cancer	0.000478	0.00168	CcSEcCtD
Moclobemide—Stomatitis—Epirubicin—uterine cancer	0.000475	0.00167	CcSEcCtD
Moclobemide—Constipation—Etoposide—uterine cancer	0.000474	0.00167	CcSEcCtD
Moclobemide—Conjunctivitis—Epirubicin—uterine cancer	0.000474	0.00166	CcSEcCtD
Moclobemide—Dysuria—Doxorubicin—uterine cancer	0.000473	0.00166	CcSEcCtD
Moclobemide—Sweating—Epirubicin—uterine cancer	0.000467	0.00164	CcSEcCtD
Moclobemide—CYP2D6—female gonad—uterine cancer	0.000458	0.0171	CbGeAlD
Moclobemide—Feeling abnormal—Etoposide—uterine cancer	0.000457	0.00161	CcSEcCtD
Moclobemide—Nausea—Dactinomycin—uterine cancer	0.000455	0.0016	CcSEcCtD
Moclobemide—Gastrointestinal pain—Etoposide—uterine cancer	0.000453	0.00159	CcSEcCtD
Moclobemide—Drowsiness—Doxorubicin—uterine cancer	0.000451	0.00158	CcSEcCtD
Moclobemide—Bradycardia—Epirubicin—uterine cancer	0.000445	0.00156	CcSEcCtD
Moclobemide—Urticaria—Etoposide—uterine cancer	0.00044	0.00155	CcSEcCtD
Moclobemide—Stomatitis—Doxorubicin—uterine cancer	0.000439	0.00154	CcSEcCtD
Moclobemide—Abdominal pain—Etoposide—uterine cancer	0.000438	0.00154	CcSEcCtD
Moclobemide—Conjunctivitis—Doxorubicin—uterine cancer	0.000438	0.00154	CcSEcCtD
Moclobemide—Sweating—Doxorubicin—uterine cancer	0.000432	0.00152	CcSEcCtD
Moclobemide—Visual impairment—Epirubicin—uterine cancer	0.000422	0.00148	CcSEcCtD
Moclobemide—Bradycardia—Doxorubicin—uterine cancer	0.000412	0.00145	CcSEcCtD
Moclobemide—Tinnitus—Epirubicin—uterine cancer	0.000408	0.00143	CcSEcCtD
Moclobemide—Flushing—Epirubicin—uterine cancer	0.000406	0.00143	CcSEcCtD
Moclobemide—Asthenia—Etoposide—uterine cancer	0.000398	0.0014	CcSEcCtD
Moclobemide—Pruritus—Etoposide—uterine cancer	0.000392	0.00138	CcSEcCtD
Moclobemide—Visual impairment—Doxorubicin—uterine cancer	0.00039	0.00137	CcSEcCtD
Moclobemide—Diarrhoea—Etoposide—uterine cancer	0.000379	0.00133	CcSEcCtD
Moclobemide—Tinnitus—Doxorubicin—uterine cancer	0.000377	0.00133	CcSEcCtD
Moclobemide—Flushing—Doxorubicin—uterine cancer	0.000376	0.00132	CcSEcCtD
Moclobemide—Flatulence—Epirubicin—uterine cancer	0.000375	0.00132	CcSEcCtD
Moclobemide—Tension—Epirubicin—uterine cancer	0.000374	0.00131	CcSEcCtD
Moclobemide—Dysgeusia—Epirubicin—uterine cancer	0.000373	0.00131	CcSEcCtD
Moclobemide—Nervousness—Epirubicin—uterine cancer	0.00037	0.0013	CcSEcCtD
Moclobemide—Dizziness—Etoposide—uterine cancer	0.000367	0.00129	CcSEcCtD
Moclobemide—Vision blurred—Epirubicin—uterine cancer	0.000359	0.00126	CcSEcCtD
Moclobemide—Ill-defined disorder—Epirubicin—uterine cancer	0.000353	0.00124	CcSEcCtD
Moclobemide—Vomiting—Etoposide—uterine cancer	0.000352	0.00124	CcSEcCtD
Moclobemide—Agitation—Epirubicin—uterine cancer	0.00035	0.00123	CcSEcCtD
Moclobemide—Rash—Etoposide—uterine cancer	0.00035	0.00123	CcSEcCtD
Moclobemide—Dermatitis—Etoposide—uterine cancer	0.000349	0.00123	CcSEcCtD
Moclobemide—Headache—Etoposide—uterine cancer	0.000347	0.00122	CcSEcCtD
Moclobemide—Flatulence—Doxorubicin—uterine cancer	0.000347	0.00122	CcSEcCtD
Moclobemide—Tension—Doxorubicin—uterine cancer	0.000346	0.00121	CcSEcCtD
Moclobemide—Dysgeusia—Doxorubicin—uterine cancer	0.000345	0.00121	CcSEcCtD
Moclobemide—Malaise—Epirubicin—uterine cancer	0.000343	0.00121	CcSEcCtD
Moclobemide—Nervousness—Doxorubicin—uterine cancer	0.000342	0.0012	CcSEcCtD
Moclobemide—Syncope—Epirubicin—uterine cancer	0.000341	0.0012	CcSEcCtD
Moclobemide—Palpitations—Epirubicin—uterine cancer	0.000336	0.00118	CcSEcCtD
Moclobemide—Loss of consciousness—Epirubicin—uterine cancer	0.000335	0.00118	CcSEcCtD
Moclobemide—Vision blurred—Doxorubicin—uterine cancer	0.000332	0.00117	CcSEcCtD
Moclobemide—Nausea—Etoposide—uterine cancer	0.000329	0.00116	CcSEcCtD
Moclobemide—Hypertension—Epirubicin—uterine cancer	0.000329	0.00116	CcSEcCtD
Moclobemide—Ill-defined disorder—Doxorubicin—uterine cancer	0.000327	0.00115	CcSEcCtD
Moclobemide—Myalgia—Epirubicin—uterine cancer	0.000324	0.00114	CcSEcCtD
Moclobemide—Chest pain—Epirubicin—uterine cancer	0.000324	0.00114	CcSEcCtD
Moclobemide—Agitation—Doxorubicin—uterine cancer	0.000324	0.00114	CcSEcCtD
Moclobemide—Anxiety—Epirubicin—uterine cancer	0.000323	0.00114	CcSEcCtD
Moclobemide—Discomfort—Epirubicin—uterine cancer	0.00032	0.00113	CcSEcCtD
Moclobemide—Malaise—Doxorubicin—uterine cancer	0.000318	0.00112	CcSEcCtD
Moclobemide—Dry mouth—Epirubicin—uterine cancer	0.000317	0.00111	CcSEcCtD
Moclobemide—Syncope—Doxorubicin—uterine cancer	0.000316	0.00111	CcSEcCtD
Moclobemide—Confusional state—Epirubicin—uterine cancer	0.000313	0.0011	CcSEcCtD
Moclobemide—Palpitations—Doxorubicin—uterine cancer	0.000311	0.00109	CcSEcCtD
Moclobemide—Loss of consciousness—Doxorubicin—uterine cancer	0.00031	0.00109	CcSEcCtD
Moclobemide—Shock—Epirubicin—uterine cancer	0.000306	0.00107	CcSEcCtD
Moclobemide—Hypertension—Doxorubicin—uterine cancer	0.000304	0.00107	CcSEcCtD
Moclobemide—Tachycardia—Epirubicin—uterine cancer	0.000303	0.00107	CcSEcCtD
Moclobemide—Hyperhidrosis—Epirubicin—uterine cancer	0.0003	0.00106	CcSEcCtD
Moclobemide—Myalgia—Doxorubicin—uterine cancer	0.0003	0.00105	CcSEcCtD
Moclobemide—Chest pain—Doxorubicin—uterine cancer	0.0003	0.00105	CcSEcCtD
Moclobemide—Anxiety—Doxorubicin—uterine cancer	0.000299	0.00105	CcSEcCtD
Moclobemide—Discomfort—Doxorubicin—uterine cancer	0.000296	0.00104	CcSEcCtD
Moclobemide—Dry mouth—Doxorubicin—uterine cancer	0.000293	0.00103	CcSEcCtD
Moclobemide—Hypotension—Epirubicin—uterine cancer	0.00029	0.00102	CcSEcCtD
Moclobemide—Confusional state—Doxorubicin—uterine cancer	0.00029	0.00102	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000283	0.000995	CcSEcCtD
Moclobemide—Shock—Doxorubicin—uterine cancer	0.000283	0.000994	CcSEcCtD
Moclobemide—Insomnia—Epirubicin—uterine cancer	0.000281	0.000988	CcSEcCtD
Moclobemide—Tachycardia—Doxorubicin—uterine cancer	0.000281	0.000986	CcSEcCtD
Moclobemide—Paraesthesia—Epirubicin—uterine cancer	0.000279	0.000981	CcSEcCtD
Moclobemide—Hyperhidrosis—Doxorubicin—uterine cancer	0.000278	0.000977	CcSEcCtD
Moclobemide—Dyspnoea—Epirubicin—uterine cancer	0.000277	0.000974	CcSEcCtD
Moclobemide—Somnolence—Epirubicin—uterine cancer	0.000276	0.000971	CcSEcCtD
Moclobemide—Dyspepsia—Epirubicin—uterine cancer	0.000274	0.000961	CcSEcCtD
Moclobemide—Decreased appetite—Epirubicin—uterine cancer	0.00027	0.000949	CcSEcCtD
Moclobemide—Hypotension—Doxorubicin—uterine cancer	0.000269	0.000944	CcSEcCtD
Moclobemide—Fatigue—Epirubicin—uterine cancer	0.000268	0.000942	CcSEcCtD
Moclobemide—Constipation—Epirubicin—uterine cancer	0.000266	0.000934	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000262	0.000921	CcSEcCtD
Moclobemide—Insomnia—Doxorubicin—uterine cancer	0.00026	0.000914	CcSEcCtD
Moclobemide—Paraesthesia—Doxorubicin—uterine cancer	0.000258	0.000907	CcSEcCtD
Moclobemide—Dyspnoea—Doxorubicin—uterine cancer	0.000256	0.000901	CcSEcCtD
Moclobemide—Feeling abnormal—Epirubicin—uterine cancer	0.000256	0.0009	CcSEcCtD
Moclobemide—Somnolence—Doxorubicin—uterine cancer	0.000256	0.000898	CcSEcCtD
Moclobemide—Gastrointestinal pain—Epirubicin—uterine cancer	0.000254	0.000893	CcSEcCtD
Moclobemide—Dyspepsia—Doxorubicin—uterine cancer	0.000253	0.000889	CcSEcCtD
Moclobemide—Decreased appetite—Doxorubicin—uterine cancer	0.00025	0.000878	CcSEcCtD
Moclobemide—Fatigue—Doxorubicin—uterine cancer	0.000248	0.000871	CcSEcCtD
Moclobemide—Urticaria—Epirubicin—uterine cancer	0.000247	0.000868	CcSEcCtD
Moclobemide—Constipation—Doxorubicin—uterine cancer	0.000246	0.000864	CcSEcCtD
Moclobemide—Abdominal pain—Epirubicin—uterine cancer	0.000246	0.000863	CcSEcCtD
Moclobemide—Feeling abnormal—Doxorubicin—uterine cancer	0.000237	0.000833	CcSEcCtD
Moclobemide—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000235	0.000826	CcSEcCtD
Moclobemide—Urticaria—Doxorubicin—uterine cancer	0.000228	0.000803	CcSEcCtD
Moclobemide—Abdominal pain—Doxorubicin—uterine cancer	0.000227	0.000799	CcSEcCtD
Moclobemide—Asthenia—Epirubicin—uterine cancer	0.000223	0.000784	CcSEcCtD
Moclobemide—Pruritus—Epirubicin—uterine cancer	0.00022	0.000773	CcSEcCtD
Moclobemide—Diarrhoea—Epirubicin—uterine cancer	0.000213	0.000747	CcSEcCtD
Moclobemide—Asthenia—Doxorubicin—uterine cancer	0.000206	0.000725	CcSEcCtD
Moclobemide—Dizziness—Epirubicin—uterine cancer	0.000205	0.000722	CcSEcCtD
Moclobemide—Pruritus—Doxorubicin—uterine cancer	0.000203	0.000715	CcSEcCtD
Moclobemide—Vomiting—Epirubicin—uterine cancer	0.000198	0.000694	CcSEcCtD
Moclobemide—Diarrhoea—Doxorubicin—uterine cancer	0.000197	0.000691	CcSEcCtD
Moclobemide—Rash—Epirubicin—uterine cancer	0.000196	0.000689	CcSEcCtD
Moclobemide—Dermatitis—Epirubicin—uterine cancer	0.000196	0.000688	CcSEcCtD
Moclobemide—Headache—Epirubicin—uterine cancer	0.000195	0.000684	CcSEcCtD
Moclobemide—Dizziness—Doxorubicin—uterine cancer	0.00019	0.000668	CcSEcCtD
Moclobemide—Nausea—Epirubicin—uterine cancer	0.000185	0.000649	CcSEcCtD
Moclobemide—Vomiting—Doxorubicin—uterine cancer	0.000183	0.000642	CcSEcCtD
Moclobemide—Rash—Doxorubicin—uterine cancer	0.000181	0.000637	CcSEcCtD
Moclobemide—Dermatitis—Doxorubicin—uterine cancer	0.000181	0.000637	CcSEcCtD
Moclobemide—Headache—Doxorubicin—uterine cancer	0.00018	0.000633	CcSEcCtD
Moclobemide—Nausea—Doxorubicin—uterine cancer	0.000171	0.0006	CcSEcCtD
